KLOW is an 80mg research blend containing GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg. It is supplied as a single lyophilised material for controlled laboratory studies of extracellular-matrix regulation, cell migration, inflammatory signalling and tissue-remodelling pathways.
Research blend only
This material is not supplied as a medicine, treatment, cosmetic, supplement or consumer product. It is not for human or veterinary use, consumption or administration, and is not intended to diagnose, treat, cure or prevent any disease.
Blend overview
Research context
The KLOW formulation combines four separately named research materials in one vial. Published studies have investigated GHK-Cu in fibroblast and extracellular-matrix models, BPC-157 in preclinical tendon and tissue models, thymosin beta-4 in cell-migration and wound-repair models, and KPV in cellular and animal models of inflammatory signalling. These studies concern individual materials under their authors’ experimental conditions. They are not evidence for the performance, interactions or suitability of this exact combined formulation.
TB-500 is a research-market designation. Literature concerning thymosin beta-4 provides related scientific context but should not be treated as proof that every material sold under the TB-500 name is chemically identical. Use the applicable batch documentation when assessing component identity.
Batch documentation
Independent analytical documentation is published where available for specific batches and variations. A result indicator appears only when a published record is available. Match the product, stated composition and batch identifier to the corresponding report before relying on any result.
View available KLOW lab results →
Supply and laboratory handling
- Supplied as a single vial containing the component amounts stated above.
- Keep the sealed lyophilised vial dry and protected from direct light.
- A cool, dry place, refrigerator or freezer may be used according to the intended storage duration, component-specific information and your laboratory’s validated procedure.
- Use clean laboratory technique and equipment appropriate to the intended analytical method.
- Follow the lot-specific documentation and your laboratory’s validated handling and storage procedures.
- Avoid repeated temperature cycling and unnecessary exposure to moisture.
Where a batch document or supplier specification gives different instructions, the lot-specific document takes precedence.
Frequently asked questions
What does the KLOW blend contain?
Each 80mg vial is labelled as containing GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg.
Has this exact blend been studied?
The references provided in the Research tab concern the individual named components or related research material. No published study of this exact four-component formulation is cited, and component findings should not be assumed to describe the combined blend.
Which vial sizes are available?
Current vial sizes, stock, pre-order status, pricing and any batch-documentation indicators are shown in the variation selector above.
Does every batch have a published laboratory result?
No. Results are available only for the selected batches marked with a result indicator. Always check that the product, composition and batch identifier match the report.
How should the material be stored?
Keep the sealed lyophilised blend dry and protected from light. A cool, dry place, refrigerator or freezer may be used according to the intended storage duration, component-specific information and your laboratory’s validated procedure. Avoid repeated temperature cycling and moisture exposure. No universal shelf-life is stated unless it is supported by batch documentation.
Information reviewed: 29 August 2026.
